"10.1371_journal.pone.0090018","plos one","2014-02-28T00:00:00Z","Abraham B Roos; Michiko Mori; Reidar Grönneberg; Christina Österlund; Hans-Erik Claesson; Jan Wahlström; Johan Grunewald; Anders Eklund; Jonas S Erjefält; Jon O Lundberg; Magnus Nord","Department of Medicine, Solna, Respiratory Medicine Unit, Karolinska Institutet, Stockholm, Sweden; Department of Experimental Medical Science, Lund University, Lund, Sweden; Department of Medicine, Division of Hematology, Karolinska Institutet, Stockholm, Sweden; Department of Physiology and Pharmacology, Section of Pharmacological Nitric Oxide Research, Karolinska Institutet, Stockholm, Sweden; Safety Science, Global Regulatory Affairs & Patient Safety, AstraZeneca Global Medicines Development, Mölndal, Sweden","Conceived and designed the experiments: AR H-EC JW AE JG JSE JOL MN. Performed the experiments: AR MM RG CÖ AE. Analyzed the data: AR MM CÖ JSE JOL MN. Contributed reagents/materials/analysis tools: H-EC AE JG JSE JOL MN. Wrote the paper: AR MM CÖ H-EC JW AE JG JSE JOL MN.","AR has received a lecturer fee from Boehringer Ingelheim and travel grants from AstraZeneca R&D. MN is a full time employee of AstraZeneca R&D. AR, JG and MN have received research grants from AstraZeneca R&D. There are no patents, products in development or marketed products to declare. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.","2014","02","Abraham B Roos","ABR",11,TRUE,8,5,6,10,TRUE,TRUE,FALSE,0,NA,FALSE
